List of Contributors
Juan Carlos Abad, Jason J.S. Barton(Beth Israel Deaconess Medical Center), Robin K. Avery(Johns Hopkins University), Fahd Anzaar, Ibrahim A Al Jadaan, Fina C. Barouch, R. David Anderson(Cancer Trials Ireland), Robert C. Allen, Hassan Alizadeh(Centre National de la Recherche Scientifique), Isabelle Audo(Inserm), Penny A. Asbell(University of Memphis), Albert Alm, T. J. Alexandrou, Daniel M. Albert(Oregon Health & Science University), Gerd U. Auffarth(Heidelberg University), Lloyd Paul Aiello(Joslin Diabetes Center), David H. Abramson(Memorial Sloan Kettering Cancer Center), Dimitri T. Azar(University of Illinois Chicago), Pablo Artal(Universidad San Pablo), Calliope E Allen, Wesley H Adams, Pelin Atmaca-Sönmez, Jorge L Alié, Ann S Baker, Claudia A. Arrigg, Sofia Androudi(University of Thessaly), Martin A. Acquadro, George B. Bartley(Mayo Clinic), Mark Balles, George K. Asdourian, Samar A. Al-Swailem(King Khaled Eye Specialist Hospital), Sabah Al-Jastaneiah, Marissa L Albano, Donald M. Barnett, Natalie A. Afshari(Smith-Kettlewell Eye Research Institute), Neal P. Barney, Eduardo C. Alfonso(University of Miami Health System), Leonard PK Ang, Anthony P. Adamis(Massachusetts Eye and Ear Infirmary), Christopher M. Andreoli, Abigail K Alt, David T. Allen(The University of Texas at Austin), Neal H. Atebara(University of Hawaiʻi at Mānoa), Everett Ai, David J. Apple, Mark B. Abelson(Harvard University), Scott D. Barnes, Levent Akduman, Lloyd M. Aiello(Joslin Diabetes Center), Michael M. Altaweel(University of Wisconsin–Madison)
Cited by 0
Related Papers
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|5k
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
|The Lancet Global Health|2020|1.3k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k